Necrolytic Migratory Erythema—A Case Report of Pancreatic Occupying Lesion

HU Zhonghui; YANG Lu; LIU Yuehua; JIN Hongzhong; XU Qiang; LIU Wenjing; LUO Yaping; YANG Hongbo; WANG Tao

doi:10.12376/j.issn.2097-0501.2023.03.014

Journal of Rare Diseases > 2023 > 2(3): 427-431. > DOI: 10.12376/j.issn.2097-0501.2023.03.014

HU Zhonghui, YANG Lu, LIU Yuehua, JIN Hongzhong, XU Qiang, LIU Wenjing, LUO Yaping, YANG Hongbo, WANG Tao. Necrolytic Migratory Erythema—A Case Report of Pancreatic Occupying Lesion[J]. Journal of Rare Diseases, 2023, 2(3): 427-431. DOI: 10.12376/j.issn.2097-0501.2023.03.014

Citation:

PDF (2324 KB)

Necrolytic Migratory Erythema—A Case Report of Pancreatic Occupying Lesion

1.
Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
2.
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
3.
Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
4.
Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds:

National High Level Hospital Clinical Research Funding 2022-PUMCH-A-164

Beijing Natural Science Foundation Z210017

More Information

Corresponding author:
WANG Tao, E-mail: wangtaopumch@126.com
Received Date: July 11, 2022
Accepted Date: September 22, 2022
Available Online: September 08, 2023

Graphical Abstract

Abstract

Abstract

Glucagonoma is a rare neuroendocrine tumor of α cells of the pancreas. The tumor excessively secretes glucagon and causes glucagonoma syndrome.70%-90% of patients with glucagonoma will develop necrolytic migratory erythema (NME). We reported a patient of glucagonoma syndrome who was presented to the dermatology outpatient clinic with a 2-year-history of recurrent erythema and scaling on the skin migrating throughout the body. A skin biopsy was performed and resulting features matched with NME, whilst imaging examinations suggested a soft tissue density tumor present in the tail of the pancreas with somatostatin receptor expression and laboratory tests found an elevated levels of serum glucagon. After the diagnosis was confirmed, the patient was treated with surgical resection of the glucagonoma and the skin eruptions resolved rapidly in 4 days. Meanwhile, we reviewed relevant literature published in recent years and summarized its clinical characteristics in order to improve its understanding by clinicians, including clinical manifestations, laboratory and imaging examinations, diagnosis and treatments.
- necrolytic migratory erythema,
- glucagonoma,
- glucagonoma syndrome,
- pancreatic occupying lesion

FullText(HTML)

References (19)

References

[1]	Luber AJ, Ackerman LS, Culpepper KS, et al. Paediatric necrolytic migratory erythema as a presenting sign of glucagonoma syndrome[J]. Br J Dermatol, 2016, 174(5): 1092-1095. doi: 10.1111/bjd.14298
[2]	Al-Faouri A, Ajarma K, Alghazawi S, et al. Glucagonoma and glucagonoma syndrome: a case report with review of recent advances in management[J]. Case Rep Surg, 2016, 2016: 1484089.
[3]	Wermers RA, Fatourechi V, Wynne AG, et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients[J]. Medicine (Baltimore), 1996, 75(2): 53-63. doi: 10.1097/00005792-199603000-00002
[4]	Tolliver S, Graham J, Kaffenberger BH. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema[J]. Int J Dermatol, 2018, 57(6): 642-645. doi: 10.1111/ijd.13947
[5]	Daly DM, Thompson B, Low J, et al. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema[J]. ANZ J Surg, 2019, 89(5): 599-602. doi: 10.1111/ans.14186
[6]	Remes-Troche JM, García-de-Acevedo B, Zuñiga-Varga J, et al. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome[J]. J Eur Acad Dermatol Venereol, 2004, 18(5): 591-595. doi: 10.1111/j.1468-3083.2004.00981.x
[7]	Liu JW, Qian YT, Ma DL. Necrolytic migratory erythema[J]. JAMA Dermatol, 2019, 155(10): 1180. doi: 10.1001/jamadermatol.2019.1658
[8]	John AM, Schwartz RA. Glucagonoma syndrome: a review and update on treatment[J]. J Eur Acad Dermatol Venereol, 2016, 30(12): 2016-2022. doi: 10.1111/jdv.13752
[9]	Compton NL, Chien AJ. A rare but revealing sign: necrolytic migratory erythema[J]. Am J Med, 2013, 126(5): 387-389. doi: 10.1016/j.amjmed.2013.01.012
[10]	Gracia-Darder I, Ramos D, Boix-Vilanova J, et al. Necrolytic migratory erythema associated with painful plantar keratoderma. A new diagnostic clue for this paraneoplastic syndrome?[J]. An Bras Dermatol, 2020, 95(5): 666-668. doi: 10.1016/j.abd.2020.02.011
[11]	Kitamura Y, Sato M, Hatamochi A, et al. Necrolytic migratory erythema without glucagonoma associated with hepatitis B[J]. Eur J Dermatol, 2005, 15(1): 49-51.
[12]	Chiyomaru K, Takai T, Ohashi A, et al. Necrolytic migratory erythema with cholangiocarcinoma: pseudoglucagonoma syndrome[J]. Eur J Dermatol, 2010, 20(2): 238-239. doi: 10.1684/ejd.2010.0878
[13]	Technau K, Renkl A, Norgauer J, et al. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma[J]. Eur J Dermatol, 2005, 15(2): 110-112.
[14]	Lobo I, Carvalho A, Amaral C, et al. Glucagonoma syndrome and necrolytic migratory erythema[J]. Int J Dermatol, 2010, 49(1): 24-29. doi: 10.1111/j.1365-4632.2009.04220.x
[15]	Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)[J]. Gut, 2012, 61(1): 6-32. doi: 10.1136/gutjnl-2011-300831
[16]	Zhu WF, Zheng SS. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation[J]. Hepatobiliary Pancreat Dis Int, 2021, 20(6): 598-600. doi: 10.1016/j.hbpd.2021.09.005
[17]	Wu SL, Bai JG, Xu J, et al. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor[J]. World J Surg Oncol, 2014, 12: 220. doi: 10.1186/1477-7819-12-220
[18]	Jiménez-Gallo D, Ossorio-García L, de la Varga-Martínez R, et al. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine[J]. Dermatol Ther, 2017, 30(4). 10.1111/dth. 12498.
[19]	Tremblay C, Marcil I. Necrolytic migratory erythema: a forgotten paraneoplastic condition[J]. J Cutan Med Surg, 2017, 21(6): 559-561. doi: 10.1177/1203475417719051

[1]	Hypothalamic and Pituitary Disease Group of China Alliance for Rare Diseases. Chinese Experts′ Consensus on the Management of Hypothalamic Obesity Secondary to Sellar Lesions[J]. Journal of Rare Diseases, 2024, 3(4): 479-491. DOI: 10.12376/j.issn.2097-0501.2024.04.011
[2]	CHEN Yu, LI Jianwei, TAN Huiwen, YU Yerong. A Case Report of Marfan Syndrome with Pituitary Tumor Which Could be Misdiagnosed as Gigantism[J]. Journal of Rare Diseases, 2024, 3(2): 237-240. DOI: 10.12376/j.issn.2097-0501.2024.02.013
[3]	JIN Yuanmeng, ZHANG Chunli, XU Jing, XIE Jingyuan. A Case Report of MYH9 Gene Mutation Associated with Glomerular Minor Lesion[J]. Journal of Rare Diseases, 2024, 3(1): 131-135. DOI: 10.12376/j.issn.2097-0501.2024.01.018
[4]	CAO Yaqing, GUO Baocheng, NIE Min. Genotype-Phenotype Correlation Analysis of WT1 Gene Variants in Denys-Drash Syndrome and Frasier Syndrome[J]. Journal of Rare Diseases, 2024, 3(1): 63-76. DOI: 10.12376/j.issn.2097-0501.2024.01.009
[5]	CHEN Dan, SUN Liying, ZHONG Wenyao, TIAN Wen. A Case Report of Nail-Patella Syndrome[J]. Journal of Rare Diseases, 2023, 2(4): 611-615. DOI: 10.12376/j.issn.2097-0501.2023.04.018
[6]	LI Guozhuang, XU Kexin, ZHAO Sen, ZHANG Jianguo, QIU Guixing, SUI Ruifang, WANG Tao, SHEN Min, ZENG Xuejun, WANG Wei, MA Mingsheng, WEI Min, LONG Xiao, LYU Ke, HUO Li, XUAN Lei, WU Nan. A Case Report of Blau Syndrome[J]. Journal of Rare Diseases, 2023, 2(4): 547-553. DOI: 10.12376/j.issn.2097-0501.2023.04.012
[7]	ZHAO Yuxing, DUAN Lian, LYU Wei, YAO Yong, YOU Hui, ZHANG Wen, MA Jin, MAO Xinxin, ZHU Huijuan. Rare Manifestations of Common Diseases: Middle-Aged Male Polyuria-Headache-Inflammatory Granulomatous Lesions[J]. Journal of Rare Diseases, 2023, 2(3): 359-364. DOI: 10.12376/j.issn.2097-0501.2023.03.007
[8]	Chinese Research Hospital Association- Children's Oncology Committee, FUTang Research Center of Pediatric Development- Children's Oncology Committee, FUTang Research Center of Pediatric Development- Children's Neurology Committee. Recommendations for Neuroblastoma Associated Opsoclonus-myoclonus-ataxia Syndrome in Childhood[J]. Journal of Rare Diseases, 2022, 1(3): 304-310. DOI: 10.12376/j.issn.2097-0501.2022.03.012
[9]	ZHONG Linqing, MA Mingsheng, SUI Ruifang, HONG Xia, FENG Feng, HUO Li, DAI Menghua, XU Qiang, SONG Hongmei. Multidisciplinary Treatment on a Case of ROSAH Syndrome[J]. Journal of Rare Diseases, 2022, 1(3): 289-295. DOI: 10.12376/j.issn.2097-0501.2022.03.010
[10]	HONG Yuehui, SHEN Min, WANG Tao, MA Mingsheng, ZHAO Sen, FENG Feng, ZHAO Dachun, ZHANG Wen, ZENG Xuejun, XUAN Lei, YAO Ming, ZHU Yicheng. An Adolescent with Recurrent Intracranial Hemorrhage, and Skin Lesion[J]. Journal of Rare Diseases, 2022, 1(2): 151-157. DOI: 10.12376/j.issn.2097-0501.2022.02.009

Cited By

Cited by

Periodical cited type(1)

张牧秋，汪盛. 坏死松解性游走性红斑1例. 中国皮肤性病学杂志. 2025(01): 105-108 .

Other cited types(0)

Get Citation

PDF

XML

Article views (146) PDF downloads (32) Cited by(1)

Turn off MathJax

Article Contents

Abstract

References

Necrolytic Migratory Erythema—A Case Report of Pancreatic Occupying Lesion